The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease - Poll - MDSpire

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • By

  • Yingte Wang

  • Hong Li

  • Jing Zhou

  • Saiyao Zhao

  • Airong Yang

  • Zhiming Li

  • May 8, 2026

  • 0 min

Share

Original Source(s)

The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease

  • by Yingte Wang, Hong Li, Jing Zhou, Saiyao Zhao, Airong Yang, Zhiming Li

  • May 8, 2026

Related Content

Associations of Individual- and Neighborhood-Level Factors with Racial and Ethnic Disparities in Timely Dementia Diagnosis

Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study

ARPA-H Launches New Program to Deliver Rigorous, Gold-Standard Research Faster